Report Summary
The global Porcine Circovirus Vaccine market is valued at million US$ in 2020 and will reach million US$ by the end of 2027, growing at a CAGR of during 2021-2027. The objectives of this study are to define, segment, and project the size of the Porcine Circovirus Vaccine market based on company, product type, end user and key regions.
This report studies the global market size of Porcine Circovirus Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Porcine Circovirus Vaccine in these regions.
This research report categorizes the global Porcine Circovirus Vaccine market by top players/brands, region, type and end user. This report also studies the global Porcine Circovirus Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Chopper Biology
ChengDu Tecbond
Ringpu Biology
Qilu Animal
DHN
CAVAC
Komipharm
Jinyu Bio-Technology
Zoetis
Merial
Market size by Product
Genetic Engineering Vaccine
Killed Vaccines
Market size by End User
Piglets
Adults Pigs
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Porcine Circovirus Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2020, and forecast to 2027.
To understand the structure of Porcine Circovirus Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Porcine Circovirus Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Porcine Circovirus Vaccine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Porcine Circovirus Vaccine are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2027
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Porcine Circovirus Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table Of Contents
Table of Contents
1 Study Coverage
1.1 Porcine Circovirus Vaccine Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Porcine Circovirus Vaccine Market Size Growth Rate by Product
1.4.2 Genetic Engineering Vaccine
1.4.3 Killed Vaccines
1.5 Market by End User
1.5.1 Global Porcine Circovirus Vaccine Market Size Growth Rate by End User
1.5.2 Piglets
1.5.3 Adults Pigs
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Porcine Circovirus Vaccine Market Size
2.1.1 Global Porcine Circovirus Vaccine Revenue 2017-2027
2.1.2 Global Porcine Circovirus Vaccine Sales 2017-2027
2.2 Porcine Circovirus Vaccine Growth Rate by Regions
2.2.1 Global Porcine Circovirus Vaccine Sales by Regions
2.2.2 Global Porcine Circovirus Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Porcine Circovirus Vaccine Sales by Manufacturers
3.1.1 Porcine Circovirus Vaccine Sales by Manufacturers
3.1.2 Porcine Circovirus Vaccine Sales Market Share by Manufacturers
3.1.3 Global Porcine Circovirus Vaccine Market Concentration Ratio (CR5 and HHI)
3.2 Porcine Circovirus Vaccine Revenue by Manufacturers
3.2.1 Porcine Circovirus Vaccine Revenue by Manufacturers (2017-2020)
3.2.2 Porcine Circovirus Vaccine Revenue Share by Manufacturers (2017-2020)
3.3 Porcine Circovirus Vaccine Price by Manufacturers
3.4 Porcine Circovirus Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Porcine Circovirus Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Porcine Circovirus Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Porcine Circovirus Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Porcine Circovirus Vaccine Sales by Product
4.2 Global Porcine Circovirus Vaccine Revenue by Product
4.3 Porcine Circovirus Vaccine Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Porcine Circovirus Vaccine Breakdown Data by End User
6 North America
6.1 North America Porcine Circovirus Vaccine by Countries
6.1.1 North America Porcine Circovirus Vaccine Sales by Countries
6.1.2 North America Porcine Circovirus Vaccine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Porcine Circovirus Vaccine by Product
6.3 North America Porcine Circovirus Vaccine by End User
7 Europe
7.1 Europe Porcine Circovirus Vaccine by Countries
7.1.1 Europe Porcine Circovirus Vaccine Sales by Countries
7.1.2 Europe Porcine Circovirus Vaccine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Porcine Circovirus Vaccine by Product
7.3 Europe Porcine Circovirus Vaccine by End User
8 Asia Pacific
8.1 Asia Pacific Porcine Circovirus Vaccine by Countries
8.1.1 Asia Pacific Porcine Circovirus Vaccine Sales by Countries
8.1.2 Asia Pacific Porcine Circovirus Vaccine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Porcine Circovirus Vaccine by Product
8.3 Asia Pacific Porcine Circovirus Vaccine by End User
9 Central & South America
9.1 Central & South America Porcine Circovirus Vaccine by Countries
9.1.1 Central & South America Porcine Circovirus Vaccine Sales by Countries
9.1.2 Central & South America Porcine Circovirus Vaccine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Porcine Circovirus Vaccine by Product
9.3 Central & South America Porcine Circovirus Vaccine by End User
10 Middle East and Africa
10.1 Middle East and Africa Porcine Circovirus Vaccine by Countries
10.1.1 Middle East and Africa Porcine Circovirus Vaccine Sales by Countries
10.1.2 Middle East and Africa Porcine Circovirus Vaccine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Porcine Circovirus Vaccine by Product
10.3 Middle East and Africa Porcine Circovirus Vaccine by End User
11 Company Profiles
11.1 Chopper Biology
11.1.1 Chopper Biology Company Details
11.1.2 Company Business Overview
11.1.3 Chopper Biology Porcine Circovirus Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.1.4 Chopper Biology Porcine Circovirus Vaccine Products Offered
11.1.5 Chopper Biology Recent Development
11.2 ChengDu Tecbond
11.2.1 ChengDu Tecbond Company Details
11.2.2 Company Business Overview
11.2.3 ChengDu Tecbond Porcine Circovirus Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.2.4 ChengDu Tecbond Porcine Circovirus Vaccine Products Offered
11.2.5 ChengDu Tecbond Recent Development
11.3 Ringpu Biology
11.3.1 Ringpu Biology Company Details
11.3.2 Company Business Overview
11.3.3 Ringpu Biology Porcine Circovirus Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.3.4 Ringpu Biology Porcine Circovirus Vaccine Products Offered
11.3.5 Ringpu Biology Recent Development
11.4 Qilu Animal
11.4.1 Qilu Animal Company Details
11.4.2 Company Business Overview
11.4.3 Qilu Animal Porcine Circovirus Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.4.4 Qilu Animal Porcine Circovirus Vaccine Products Offered
11.4.5 Qilu Animal Recent Development
11.5 DHN
11.5.1 DHN Company Details
11.5.2 Company Business Overview
11.5.3 DHN Porcine Circovirus Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.5.4 DHN Porcine Circovirus Vaccine Products Offered
11.5.5 DHN Recent Development
11.6 CAVAC
11.6.1 CAVAC Company Details
11.6.2 Company Business Overview
11.6.3 CAVAC Porcine Circovirus Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.6.4 CAVAC Porcine Circovirus Vaccine Products Offered
11.6.5 CAVAC Recent Development
11.7 Komipharm
11.7.1 Komipharm Company Details
11.7.2 Company Business Overview
11.7.3 Komipharm Porcine Circovirus Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.7.4 Komipharm Porcine Circovirus Vaccine Products Offered
11.7.5 Komipharm Recent Development
11.8 Jinyu Bio-Technology
11.8.1 Jinyu Bio-Technology Company Details
11.8.2 Company Business Overview
11.8.3 Jinyu Bio-Technology Porcine Circovirus Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.8.4 Jinyu Bio-Technology Porcine Circovirus Vaccine Products Offered
11.8.5 Jinyu Bio-Technology Recent Development
11.9 Zoetis
11.9.1 Zoetis Company Details
11.9.2 Company Business Overview
11.9.3 Zoetis Porcine Circovirus Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.9.4 Zoetis Porcine Circovirus Vaccine Products Offered
11.9.5 Zoetis Recent Development
11.10 Merial
11.10.1 Merial Company Details
11.10.2 Company Business Overview
11.10.3 Merial Porcine Circovirus Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.10.4 Merial Porcine Circovirus Vaccine Products Offered
11.10.5 Merial Recent Development
12 Future Forecast
12.1 Porcine Circovirus Vaccine Market Forecast by Regions
12.1.1 Global Porcine Circovirus Vaccine Sales Forecast by Regions 2021-2027
12.1.2 Global Porcine Circovirus Vaccine Revenue Forecast by Regions 2021-2027
12.2 Porcine Circovirus Vaccine Market Forecast by Product
12.2.1 Global Porcine Circovirus Vaccine Sales Forecast by Product 2021-2027
12.2.2 Global Porcine Circovirus Vaccine Revenue Forecast by Product 2021-2027
12.3 Porcine Circovirus Vaccine Market Forecast by End User
12.4 North America Porcine Circovirus Vaccine Forecast
12.5 Europe Porcine Circovirus Vaccine Forecast
12.6 Asia Pacific Porcine Circovirus Vaccine Forecast
12.7 Central & South America Porcine Circovirus Vaccine Forecast
12.8 Middle East and Africa Porcine Circovirus Vaccine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Porcine Circovirus Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
